Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hematologic Neoplasms 9Myeloproliferative Disorders 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Lymphoma 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Prolymphocytic 4Leukemia, Myelomonocytic, Chronic 4Skin Neoplasms 3Sarcoma 3Rhabdomyosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Biphenotypic, Acute 3Leukemia 3Bronchiolitis Obliterans Syndrome 3

Interventions

pembrolizumab 243Carboplatin 211Pemetrexed 177Cisplatin 131Paclitaxel 113Nivolumab 101Docetaxel 87osimertinib 85durvalumab 78Specimen Handling 56atezolizumab 55Gemcitabine 52Drug Therapy 52Magnetic Resonance Spectroscopy 50Radiosurgery 48Radiotherapy 47Ipilimumab 41130-nm albumin-bound paclitaxel 39cemiplimab 38Bevacizumab 34Cetuximab 30tislelizumab 29amivantamab 22Taxes 22Platinum Compounds 20Blood Specimen Collection 20Immunotherapy 18Immune Checkpoint Inhibitors 18Radiation 17Erlotinib Hydrochloride 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Sirolimus × 1 year × Clear all
NCT01737502 2025-09-05

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer

Mayo Clinic

Phase 1/2 Completed
29 enrolled 16 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡